PGC-1alpha, a new therapeutic target in Huntington's disease?
Journal: 2006/December - Cell
ISSN: 0092-8674
Abstract:
The coactivator PGC-1alpha is a key regulator of mitochondrial biogenesis and respiration, mediating expression of several transcription factors required for these programs. Three new studies reveal that PGC-1alpha expression is downregulated in patients with Huntington's disease (HD) and in several animal models of this neurodegenerative disorder, implicating PGC-1alpha in HD pathogenesis and providing a connection between impaired energy metabolism and neurodegeneration.
Relations:
Citations
(48)
Pathways
(1)
Diseases
(2)
Chemicals
(7)
Organisms
(3)
Processes
(2)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.